1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea has been researched along with Leukocytopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergh, J; Blomquist, E; Gjedde, SB; Jensen, NV; L-Madsen, E; Mouridsen, HT; Söderberg, M; Wählby, S | 1 |
| Aapro, M; Demierre, B; Gregor, A; Ironside, JW; Malmström, P; Rampling, R; Rye, R; Sellar, R; Stewart, M; Whittle, IR | 1 |
2 trial(s) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Leukocytopenia
| Article | Year |
|---|---|
Phase I study of tauromustine administered in a weekly schedule.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Leukopenia; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Taurine; Thrombocytopenia | 1993 |
Phase II study of tauromustine in malignant glioma.
Topics: Adult; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Glioma; Humans; Leukopenia; Male; Middle Aged; Nausea; Nitrosourea Compounds; Prospective Studies; Taurine; Thrombocytopenia | 1992 |